Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Classificação em ações #27019
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Preço da ação
$0.16240909
Última sincronização: 2025-03-04
Valor de mercado
$35.68M
Variação (1 dia)
0.27%
Variação (1 ano)
0.00%
País
CN
Negociar Dali Pharmaceuticalco.,Ltd (603963)

Categoria

EPS de Dali Pharmaceuticalco.,Ltd (603963)
EPS em September 2024 TTM: $-0.02
De acordo com os últimos relatórios financeiros e o preço das ações da Dali Pharmaceuticalco.,Ltd, o EPS atual da empresa (TTM) é $-0.02. No final de 2022, a empresa teve um EPS de $-0.01, uma diminuição em relação a ao EPS de 2021, que foi de $-0.03.
Histórico de EPS da Dali Pharmaceuticalco.,Ltd de 2012 até 2026
EPS no final de cada ano
Ano EPS Alterar
2026 (TTM) $-0.02 57.00%
2023 $-0.01 8.55%
2022 $-0.01 -60.87%
2021 $-0.03 -1,400.00%
2020 0.00 -73.86%
2019 $0.01 31.34%
2018 $0.01 -85.47%
2017 $0.05 -15.72%
2016 $0.05 -22.74%
2015 $0.07 -51.80%
2014 $0.15 6.06%
2013 $0.14 0.44%
2012 $0.14 0.00%
EPS de empresas semelhantes ou concorrentes